BlackRock Fund Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
Other funds holding BSTC
EAM
NI
BIT
ECP
RHJA
NC
BlackRock Fund Advisors's BSTC Position: Q4 2016 in Review
BlackRock Fund Advisors increased its BioSpecifics Technologies Corp. (BSTC) stake by 17% in Q4 2016, buying an estimated $1.23M and bringing the position to 176,258 shares worth $9.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2586.
BlackRock Fund Advisors first reported a position in BSTC in Q2 2013 and has held it in 15 quarters since. 96 funds tracked by Wall St. Rank hold BSTC as of Q4 2016.
- BlackRock Fund Advisors held 176,258 shares of BioSpecifics Technologies Corp. worth $9.82M as of Q4 2016.
- BlackRock Fund Advisors bought 25,563 BioSpecifics Technologies Corp. shares in Q4 2016, an estimated $1.23M.
- BioSpecifics Technologies Corp. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2586 holding.
- BlackRock Fund Advisors first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and has held it in 15 quarters since.
- 96 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2016.
Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.